1. Tissue plasminogen activator in thrombolytic therapy;Collen, D.,1987
2. Proteins of the fibrinolytic system in human thrombi;Robbie, L.A.; Bennett, B.; Croll, A.M.; Brown, P.A.J.; Booth, N.A.;Thromb Haemost,1996
3. Plasmin effect on platelet glycoprotein lb-von Willebrand factor interactions;Adelman, B.; Michelson, A.D.; Loscalzo, J.; Greenberg, J.; Handin, R.I.;Blood,1985
4. A shift in balance between profibrinolytic and antifibrinolytic factors causes enhanced;Leebeek, F.W.G.; Kluft, C.; Knot, E.A.R.; De Maat, M.P.M.; Wilson, J.H.
5. Hyperfibrinolysis in hepatosplenic schistomiasis;El-Bassiouni, N.E.; El Bassiouny, A.E.; EL-Khayat, H.R.; Akl, M.M.; Omran, S.A.;J Clin Pathol,1996